Dear Chris, thank you for your review and outlook. I share your views. The connection with Novo is interesting, where I can only hope that the share gets another boost, as I have already considered pulling the ripcord.
Your performance is more than impressive. I think it's absolutely great.
The overview of the holding period of your derivatives was very informative for me, as I also dared to take the plunge.
I really need to understand better how to determine the costs of the products in advance and which providers and leverage to choose.
Could you do a post on this that makes it clear what to look out for in the product descriptions and which providers are generally cheaper or more expensive and how to find entry and exit points?
Otherwise, I'm delighted with all the interesting information you've provided over the past year and the great "conversations" in the various comments. 👍🏼
Your performance is more than impressive. I think it's absolutely great.
The overview of the holding period of your derivatives was very informative for me, as I also dared to take the plunge.
I really need to understand better how to determine the costs of the products in advance and which providers and leverage to choose.
Could you do a post on this that makes it clear what to look out for in the product descriptions and which providers are generally cheaper or more expensive and how to find entry and exit points?
Otherwise, I'm delighted with all the interesting information you've provided over the past year and the great "conversations" in the various comments. 👍🏼
•
77
•@TradingHase Thank you for your feedback. I will certainly write another post or two on the subject of derivatives in the new year. However, there is already some information in the Best of section, where I have already explained the individual products in several parts.
•
44
•@Multibagger Then I'll take another look at 👍🏼
Done, I had already read about it.
Nevertheless, I still don't fully understand the apparently large cost differences between the providers of KO products.
I need to learn something new.
Done, I had already read about it.
Nevertheless, I still don't fully understand the apparently large cost differences between the providers of KO products.
I need to learn something new.
•
44
•